**Core Concept**
Mycophenolate mofetil (MMF) is an immunosuppressive medication that inhibits the proliferation of T and B lymphocytes, playing a crucial role in preventing organ rejection in transplant patients. This is achieved through the interference with the enzyme inosine monophosphate dehydrogenase (IMPDH), which is essential for the synthesis of guanosine nucleotides in lymphocytes.

**Why the Correct Answer is Right**
Mycophenolate mofetil is a prodrug that is metabolized to its active form, mycophenolic acid (MPA), which selectively inhibits IMPDH. This inhibition leads to a reduction in the synthesis of guanosine nucleotides, thereby preventing the proliferation of lymphocytes. As a result, MMF effectively suppresses the immune response, making it an essential component in the prevention of organ rejection in transplant patients. The use of MMF has been shown to reduce the incidence of acute rejection episodes and improve graft survival rates.

**Why Each Wrong Option is Incorrect**
**Option B:** Mycobacterium tuberculosis infection requires treatment with antibiotics such as isoniazid, rifampicin, and ethambutol, which are not related to mycophenolate mofetil.
**Option C:** Leprosy is caused by Mycobacterium leprae and is treated with antibiotics such as rifampicin and dapsone, which are not related to mycophenolate mofetil.
**Option D:** Methanol poisoning is treated with fomepizole or ethanol, which are not related to mycophenolate mofetil.

**Clinical Pearl / High-Yield Fact**
Mycophenolate mofetil can cause gastrointestinal side effects such as diarrhea, nausea, and vomiting, which are often dose-limiting. It is essential to monitor patients for these side effects and adjust the dose accordingly to minimize the risk of adverse reactions.

**✓ Correct Answer: A. Prevention of organ transplantation rejection**